Physician profile
Keena Harrison
NPI 1790334696
$5,998.12
in general payments reported to CMS, 2019-2025
17 companies · $615 in 2025
The $615 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $420 · 2022: $3,211 · 2023: $1,107 · 2024: $645 · 2025: $615.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,367.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,074.71 | 2021-2025 | Wavewriter Alpha Prime 16, Superion Indirect Decompression System |
| Abbvie INC. | $1,229.85 | 2023-2025 | |
| Painteq LLC | $842.28 | 2022-2023 | Painteq |
| Hikma Pharmaceuticals USA | $206.22 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $190.47 | 2022-2023 | Ztlido |
| Allergan, INC. | $164.40 | 2022 | |
| Alkermes, INC. | $43.00 | 2024-2025 | Vivitrol |
| Biohaven Pharmaceuticals, INC. | $35.06 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $33.74 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $27.91 | 2024 | Austedo Xr |
| E.R. Squibb & Sons, L.L.C. | $26.92 | 2025 | Cobenfy |
| Biodelivery Sciences International, INC. | $24.49 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $21.97 | 2025 | Caplyta |
| Collegium Pharmaceutical, INC. | $21.67 | 2023 | Belbuca |
| Si-Bone, INC. | $21.41 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $20.68 | 2024 | Rexulti, Abilify Asimtufii |
| Redhill Biopharma INC. | $13.34 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keena Harrison listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.